Biotechnology Stocks II Performance Guide: MacroGenics, Inc. (MGNX)
MGNX has no dividends.
Table and Chart of MGNX Performance
See what a $1,000 investment in MGNX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MGNX Returns | |
|---|---|
| Start Date | Jun-30-2014 |
| Start Price | $21.73 |
| End Date | Jun-25-2024 |
| End Price | $4.29 |
| # Prices | 121 |
| Min Date | Jun-30-2022 |
| Min Price | $2.95 |
| Max Date | Jun-30-2015 |
| Max Price | $37.97 |
| Total Return | -80.26% |
| Annualized Return | -14.86% |
| Current Value of $1,000 Purchase | $197 |
| Number Returns | 7,260 |
| Average Return | -22.27% |
| Number Profitable Returns | 1,854 |
| Percent Profitable Returns | 25.54% |
| Number Unprofitable Returns | 5,406 |
| Percent Unprofitable Returns | 74.46% |
| Profitable to Unprofitable Returns Ratio | 0.34 |
| MGNX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $268,698,000 |
| Beta | 2.003 | Price to Sales | 18.68 |
| Earnings per Share | $-0.3800 |
| PE Ratio | None |
| PE to Growth Ratio | 0.01 |
| Price to Book | 7.2 |
| PRICE DATA | |
| 52 Week High | $21.88 |
| 52 Week Low | $3.14 |
| Analyst Target Price | $10.8 |
| 50-Day Moving Average | $8.93 |
| 200-Day Moving Average | $10.18 |
| FINANCIAL DATA | |
| Revenue per Share | $0.699 |
| Revenue | $43,357,000 |
| Profit Margin | -53.6% |
| Return on Equity | -21.6% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MGNX Compare Returns with S&P 500
MGNX Trendline Chart
MGNX Moving Average Chart
MGNX Stock Return Map - See Patterns of Gains and Losses
MGNX Stock Returns/Purchase Dates